101 related articles for article (PubMed ID: 7522572)
1. Characterization of an RNase H deficient mutant of human immunodeficiency virus-1 reverse transcriptase having an aspartate to asparagine change at position 498.
DeStefano JJ; Wu W; Seehra J; McCoy J; Laston D; Albone E; Fay PJ; Bambara RA
Biochim Biophys Acta; 1994 Oct; 1219(2):380-8. PubMed ID: 7522572
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis of the conserved aspartic acid 443, glutamic acid 478, asparagine 494, and aspartic acid 498 residues in the ribonuclease H domain of p66/p51 human immunodeficiency virus type I reverse transcriptase. Expression and biochemical analysis.
Mizrahi V; Brooksbank RL; Nkabinde NC
J Biol Chem; 1994 Jul; 269(30):19245-9. PubMed ID: 7518454
[TBL] [Abstract][Full Text] [Related]
3. An expanded model of replicating human immunodeficiency virus reverse transcriptase.
Wöhrl BM; Tantillo C; Arnold E; Le Grice SF
Biochemistry; 1995 Apr; 34(16):5343-56. PubMed ID: 7537089
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities.
Gopalakrishnan V; Peliska JA; Benkovic SJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10763-7. PubMed ID: 1279694
[TBL] [Abstract][Full Text] [Related]
5. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
6. Rapid kinetic analysis of a point mutant of HIV-1 reverse transcriptase lacking ribonuclease H activity.
Dudding LR; Mizrahi V
Biochemistry; 1993 Jun; 32(23):6116-20. PubMed ID: 7685188
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
[TBL] [Abstract][Full Text] [Related]
8. Truncating alpha-helix E' of p66 human immunodeficiency virus reverse transcriptase modulates RNase H function and impairs DNA strand transfer.
Ghosh M; Howard KJ; Cameron CE; Benkovic SJ; Hughes SH; Le Grice SF
J Biol Chem; 1995 Mar; 270(13):7068-76. PubMed ID: 7535765
[TBL] [Abstract][Full Text] [Related]
9. Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase.
Cirino NM; Cameron CE; Smith JS; Rausch JW; Roth MJ; Benkovic SJ; Le Grice SF
Biochemistry; 1995 Aug; 34(31):9936-43. PubMed ID: 7543283
[TBL] [Abstract][Full Text] [Related]
10. Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase.
Smith JS; Gritsman K; Roth MJ
J Virol; 1994 Sep; 68(9):5721-9. PubMed ID: 7520094
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the RNA- and DNA-dependent DNA polymerase activities of point mutants of HIV-1 reverse transcriptase lacking ribonuclease H activity.
Dudding LR; Nkabinde NC; Mizrahi V
Biochemistry; 1991 Oct; 30(43):10498-506. PubMed ID: 1718422
[TBL] [Abstract][Full Text] [Related]
12. Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptase.
Palaniappan C; Fay PJ; Bambara RA
J Biol Chem; 1995 Mar; 270(9):4861-9. PubMed ID: 7533167
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyl radical footprint analysis of human immunodeficiency virus reverse transcriptase-template.primer complexes.
Metzger W; Hermann T; Schatz O; Le Grice SF; Heumann H
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5909-13. PubMed ID: 7687057
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase.
Fan N; Rank KB; Poppe SM; Tarpley WG; Sharma SK
Biochemistry; 1996 Feb; 35(6):1911-7. PubMed ID: 8639674
[TBL] [Abstract][Full Text] [Related]
15. A recombinant ribonuclease H domain of HIV-1 reverse transcriptase that is enzymatically active.
Evans DB; Brawn K; Deibel MR; Tarpley WG; Sharma SK
J Biol Chem; 1991 Nov; 266(31):20583-5. PubMed ID: 1718968
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
Lim D; Orlova M; Goff SP
J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 reverse transcriptase-associated RNase H cleaves RNA/RNA in arrested complexes: implications for the mechanism by which RNase H discriminates between RNA/RNA and RNA/DNA.
Götte M; Fackler S; Hermann T; Perola E; Cellai L; Gross HJ; Le Grice SF; Heumann H
EMBO J; 1995 Feb; 14(4):833-41. PubMed ID: 7533725
[TBL] [Abstract][Full Text] [Related]
18. Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.
Gu J; Villanueva RA; Snyder CS; Roth MJ; Georgiadis MM
J Mol Biol; 2001 Jan; 305(2):341-59. PubMed ID: 11124910
[TBL] [Abstract][Full Text] [Related]
19. Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase.
Ben-Artzi H; Zeelon E; Gorecki M; Panet A
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):927-31. PubMed ID: 1371014
[TBL] [Abstract][Full Text] [Related]
20. An active recombinant p15 RNase H domain is functionally distinct from the RNase H domain associated with human immunodeficiency virus type 1 reverse transcriptase.
Evans DB; Fan N; Swaney SM; Tarpley WG; Sharma SK
J Biol Chem; 1994 Aug; 269(34):21741-7. PubMed ID: 7520442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
